Recently, the FDA approved the use of a radioactive dye in a brain scan test, called Amyvid. It's exciting because it means doctors are even closer now to diagnosing Alzheimer's much earlier in life. We have invited an expert at Texas Tech to explain more about this new test, and what it means to patients with dementia here in this area. Dr. Bradley Miller is a Neuropathologist at the Texas Tech Health Sciences Center.
Copyright 2012 KCBD. All rights reserved.